A £200m per year cancer drugs fund for the NHS has been confirmed by the government.
The government is also launching a consultation into how the fund should be operated. It said the fund would help cancer patients get greater access to drugs that their doctor recommends for them. The fund was originally proposed when the coalition government was formalised in May, and will provide £200m a year from April 2011 to the end of 2013. A separate £50m commitment has been available from the start of October until the end of March. According to the National Institute for Health and Clinical Excellence (NICE), each drug is considered on a case-by-case basis. Generally...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes